Hemophilia A differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 28: Line 28:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint Bleeding
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint Bleeding
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gastrointestinal bleeding
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gastrointestinal bleeding
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Genitourinary Bleeding
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin Bruises
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin Bruises
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skeletal deformity
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Muscle hematoma
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT
Line 39: Line 39:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Factor IX
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Factor IX
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fibrinogen
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fibrinogen
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |U/A
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |U/A:RBC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |S/E
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |S/E:RBC
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemophilia A
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemophilia A
Line 46: Line 46:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |      '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |      '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |          '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |          '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |     '''<big></big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |       '''<big>+</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |         '''<big>+</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |       '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |   '''<big>↓/</big>N'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |     '''<big></big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemophilia B
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemophilia B
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<big>''''''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |     '''<big></big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[von Willebrand disease]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[von Willebrand disease]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↓/</big>N'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |     '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
Line 97: Line 97:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vitamin K deficiency
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vitamin K deficiency
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<big>'''↑'''</big>
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |   '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  <big>'''↑ ↑'''</big>
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |     '''<big></big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|-
|-
Line 117: Line 117:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |   '''<big>+</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |       '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<big>''''''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big></big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|-
|-
Line 136: Line 136:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |       '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓Plt</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |        '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↑/</big>N'''
Line 151: Line 151:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Liver Failure
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Liver Failure
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |      '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |       '''<big></big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓Plt/N</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |       '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |   '''<big>/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big></big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |   '''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big></big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |   <big>''''''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|}
|}

Revision as of 07:05, 14 July 2018

Hemophilia A Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophilia A from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophilia A differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophilia A differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophilia A differential diagnosis

CDC on Hemophilia A differential diagnosis

Hemophilia A differential diagnosis in the news

Blogs on Hemophilia A differential diagnosis

Directions to Hospitals Treating Hemophilia A

Risk calculators and risk factors for Hemophilia A differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fahd Yunus, M.D. [2]

Overview

Hemophilia A must be differentiated from other diseases that cause abnormal or excessive bleeding.[1]

Differentiating Hemophilia A from other Diseases

The most important differential diagnosis is that of hemophilia B (also known as Christmas disease) or von Willebrand disease. The former is usually considered if factor VIII levels are normal in a person with a hemophilia phenotype. The latter is excluded on routine testing for that condition.

Differential Diagnosis

Other diseases which should be considered in the differential include:

Diseases Clinical manifestations Para-clinical findings Additional findings
Symptoms Physical examination
Lab Findings
Joint Bleeding Gastrointestinal bleeding Genitourinary Bleeding Skin Bruises Skeletal deformity Muscle hematoma CBC PT PTT BT Factor VIII Factor IX Fibrinogen U/A:RBC S/E:RBC
Hemophilia A + + + + + + N N N N N + +
Hemophilia B + + + + + + N N N N N + +
von Willebrand disease -/+ -/+ -/+ -/+ -/+ -/+ N N ↑/N ↓/N N
Vitamin K deficiency -/+ -/+ -/+ + - N N N N + +
Warfarin Toxicity -/+ + + + - -/+ N N N N + +
Platelets disorders - + -/+ - ↓Plt N N ↑/N
Liver Failure - + -/+ -/+ - -/+ ↓Plt/N ↑/N ↑/N ↑/N + +

References

  1. Konkle BA, Josephson NC, Nakaya Fletcher S. Hemophilia A. 2000 Sep 21 [Updated 2014 Jun 5]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www-ncbi-nlm-nih-gov.laneproxy.stanford.edu/books/NBK1404/

Template:WH Template:WS